Sponsored by Novartis Jamie Lynn Sigler opens up about self-advocacy, finding her treatment plan and why your voice should be the loudest in the room when it comes to your health.

Consano Bio, a clinical-stage biotechnology company advancing novel therapeutics designed to address serious painful orthopedic conditions, today highlighted the role of its Scientific Advisory Board ...

Model Context Protocol (MCP) has gained considerable momentum as a standard connector between LLM-powered tools and local systems, internal and external APIs, and data sources. From major clouds to ...

Most research papers assume a human will read them first. However, Google DeepMind's latest sprawling 60-page look at the road from AGI to superintelligence doesn't bother with that pretense. Section ...

AI is changing the security landscape. More and more threat groups incorporate LLMs into their reconnaissance and exploitation workflows. The notion that some vulnerabilities are too complex to ...

Researchers have discovered two vulnerabilities in the widely used Cursor AI-enabled integrated development environment (IDE) ...

Yes Bank touched a new 52-week high of ₹25.46 as investors cheered RBI's liquidity-supportive measures, attractive FCNR(B) deposit rates, and the bank's ongoing turnaround story. Backed by strong ...

There is a lack of evidence to suggest the majority of in vitro fertilization (IVF) add-ons improve fertility in patients ...

Pope Leo XIV states AI embeds ethical choices in its design, measurements, and classifications. Insights on dignity and ...

AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...

Dual-target CAR T-cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation ...